
mRNA translation targeting the proteins on ribosomes in diseases is a silently growing market area in drug discovery laced with many risks and failures at each stage. Navigating this space is not an easy task and require...
mRNA translation initiation factors are affected in many diseases, especially multiple cancers. Multiple different studies demonstrate them as targets and biomarkers for cause and progress of the disease. We have develop...
Our platform captures translating mRNA profiles (translatomic data) in response to drugs from different organs. This is useful to understand the safety and efficacy of drugs on different organs to decode on-targets, off-...